chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urine analysis abnormal, White blood cell count normal
Clinical narrative: Narrative: -Pt's son called the facility call center to report patient tested positive for COVID on 11/13/22. Son reported patient has become confused x 5 days, esp. when temp. is up. Pt has poor appetite. Patient triaged for ER. -Patient presented to facility ED on 11/23/2022. Patient c/o "COVID I think", patient c/o confusion x 3 weeks. Patient denies any N/V, pain, urinary s/s, patient denies any other symptoms besides "I'm incoherent", it all started when I got my flu shot. Patients son states he isn't eating like normal, low pulse ox at home 89% in bed, temp 101.3 last night at 0230. Pt has been taking Tylenol 1000mg. Son reports father has not felt well since 11/13. Father has felt weak, had poor appetite, feels confused at times, and stools have been loose. (NO vomiting, chest pain, or SOB). Pt wears a condom cath d/t urinary incontinence and urine has been dark - no dysuria. -Pt hospitalized at facility from 11/23 to 12/1 with PRINCIPAL DIAGNOSIS (Reason for admission after study): Covid 19 Infection Urinary Tract Infection due to ESBL + E Coli Chronic Condom Catheter Use AKI on CKD stage III RUL Opacity - suspected due to Covid 19 Infection -HOSPITAL COURSE: Pt was admitted to hospitalist service. He was started on IV ceftriaxone and IV fluids at time of admission. He did not require any supplemental oxygen so only supportive care was provided for Covid 19 infection. His renal function improved with IV fluids and discontinuation of HCTZ and lisinopril. His urine culture grew out two species of E Coli both of which were ESBL positive so antibiotics changed to IV Ertapenem which he received for 4 days. He will be discharged on oral Bactrim for 6 more days to complete 10 day course for complicated UTI.
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 68.0
Sex: M
Vaccine: COVID19-2, FLUA4, PPV
Symptoms: Dizziness, Headache, Injection site pain, Injection site swelling
Clinical narrative: Narrative: 68 year old MALE c/o severe headache, dizziness and injection site pain and swelling after her received 3 shots yesterday for flu, covid bivalent booster and pneumonia. No fever. He has been applying warm compresses to injection site. Pain has reduced now, headache resolved after he rested for 45 minutes.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Narrative: patient received a 2nd moderna bivalent booster within 2 weeks of each other
Age: 70.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Hyperaemia, Induration, Injection site pruritus, Periorbital oedema
Clinical narrative: Narrative:  Patient is a 70 year old male who received his 2nd dose of the monkeypox vaccine on 10/22/2022. After receiving the 2nd dose, an induration formed with hyperemia and itchiness at the injection site. He presented to the ED on 10/26/2022 because he noticed the development of right eye swelling (periorbital edema).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Intensive care, Metastatic neoplasm, Multiple organ dysfunction syndrome
Clinical narrative: Narrative:  Inpatient died during MICU car with consulting palliative care inpatient visit at hospital. Patient died on Nov 23,2022@02:00 while inpatient. Death was caused by: Multiorgan failure due to metastatic cancer Reporting this since pt had received an EUA vaccine for covid-19 vaccine EUA (J&J) on 5/12/2021. THIS DEATH IS NOT RELATED TO THE COVID VACCINE.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Death
Clinical narrative: Narrative: pt died at Hospital on Oct 27,2022@12:20. Pt had presented to this facility on same day of death on 10/27/2022. Appears pt died of cardiac arrest. Only info available in chart about this death which occurred at hospital included below. Pt had received a covid-19 vaccine EUA (J&J) on 6/1/2021 from facility. It appears this vaccine IS NOT RELATED TO THIS DEATH given long length of time between date of death and date pt was given the covid vaccine. Chief complaint: Cardiac arrest Primary Diagnosis:
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Narrative:
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Medication error
Clinical narrative: Narrative: Reporting medication error due to EUA requirements, Patient  received an extra COVID 19 bivalent booster dose since he reported having lost his vaccine card and had recalled haven gotten the dose. After the vaccine was administered, the patient later found his old vaccine card which showed he  already got a bivalent booster dose.
Age: 89.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: Narrative:  No ADE.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Fall, Respiratory tract congestion
Clinical narrative: Narrative: Hospital, COVID +. moderna x 3, falls,  chest congestion, wheezing, UTI, COPD exacerbation, d/c to.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection, Wheezing
Clinical narrative: Narrative: Hospital, COVID +. moderna x 3, falls,  chest congestion, wheezing, UTI, COPD exacerbation, d/c to.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test, Flow cytometry, Immunoglobulin therapy, Inappropriate schedule of product administration, Laboratory test
Clinical narrative: Patient who is Day +165 post transplant received an MMR vaccine at the patient's PCP on 11/30/22. The facility did not contact our site and patient's treating physician found out on 12/1/22 when the patient had her scheduled BMT follow-up. Treating physician contacted ID and immunology to discuss incident. Patient was given IVIG and titers were drawn on 12/1/22. This is a safety concern in terms of transplant and timing of post-transplant re-vaccinations per out institute's BMT. The drug abatacept also warns to contact physician prior to vaccinations. As of 12/5/22, patient has no symptoms and additional flow cytometry laboratory assessments were drawn to closely monitor the patient.
Age: 14.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody
Clinical narrative: Patient who is Day +165 post transplant received an MMR vaccine at the patient's PCP on 11/30/22. The facility did not contact our site and patient's treating physician found out on 12/1/22 when the patient had her scheduled BMT follow-up. Treating physician contacted ID and immunology to discuss incident. Patient was given IVIG and titers were drawn on 12/1/22. This is a safety concern in terms of transplant and timing of post-transplant re-vaccinations per out institute's BMT. The drug abatacept also warns to contact physician prior to vaccinations. As of 12/5/22, patient has no symptoms and additional flow cytometry laboratory assessments were drawn to closely monitor the patient.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Had two separate anaphylactic reactions to polyethylene glycol. In June of 2021 received the covid vaccine and had a mild reaction that did not require treatments but is now listed as an allergy due to the same components of polyethylene glycol. Subsequent issues involving the need to use an EpiPen and or other medications to stop the reaction have been required and needed with other products related to coconut.
Sex: M
Vaccine: COVID19-2
Symptoms: Deafness unilateral, Ear pain, Tinnitus
Clinical narrative: I received my 2nd Pfizer Booster shot for the covid vaccine on November 29th. My ear started hurting very badly the next day. On December 1st, I lost hearing in my right ear along with an addition of severe tinnitus.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given to patient 2 days after BUD.  Our vaccine BUD was 01/20/22, patient got vaccinated on 01/22/22. I contacted manufacturer to check what is the next step and they said that patient will be okay no need to get patient re-vaccinated since this date happened within the 2 days of stability of the vaccine. As per Pfizer they support the stability of the vaccine for 10 weeks +2 days. Which is just the time that patient got vaccinated. I contacted patient father and he is aware of this.
Age: 66.0
Sex: M
Vaccine: UNK
Symptoms: Unevaluable event
Clinical narrative: This is a horrible form. You don?t want the information do you?
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED PAST MFD EXPIRATION DATE OF 11/30/2022; ADMIN ON 12/5/22
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered below age requirement. No adverse reaction reported.
Age: 15.0
Sex: M
Vaccine: FLU4
Symptoms: Back injury, Fall, Loss of consciousness
Clinical narrative: Patient passed out, fell hitting his back on arm of chair.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Tachycardia
Clinical narrative: acceleration of the heartbeat, tachycardia as if I were going to have heart attacks
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered below age requirement. No adverse reaction reported.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site mass, Nodule, Pain in extremity, Peripheral swelling
Clinical narrative: Very swollen and painful arm and very painful lump on the back of the left shoulder
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 4/22/21, 5/13/21, 7/28/22. Positive on 11/28/22
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine breakthrough case. Pfizer 4/3/21 EL3249, 2/10/21 EM9810 and boosted 10/25/21 EW0150 and 7/19/22 FP7139.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Vaccine breakthrough infection
Clinical narrative: COVID-related death. Breakthrough case
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case. Moderna 4/3/21 018B21A, 5/1/21 040B21A and boosted 12/4/21 - NO LOT # AVAILABLE
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case Pfizer 2/2/21 EL3248,  2/23/21 EN6200 and boosted 10/12/21 FF8847 and 5/13/22 Moderna 056M21A
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Chest discomfort, Chills, Dyspnoea, Fatigue
Clinical narrative: After I received the vaccine, I felt a warm sensation in my throat. Within 30 minutes of receiving the vaccine, I had a tightening in my chest, I started experiencing, chills and my body ached all over. Within 2 hours of receiving the vaccine, I was still experiencing the same symptoms but they were getting worse. Within 4 hours I felt I couldn't move and all I wanted to do was lay down.I slept for an hour. The symptoms were worse and I was short of breath and my head was swimming, I hurt all over, inside and out. I couldn't get up. I was like this for almost 16 hours. After 48 hours I was able to get to the bathroom and take a bath but symptoms were still there. After 6 more hours my fever broke. Its been 7 days and I am still experiencing a headache, body aches, chills, tightness of the chest, shortness of breath, my head is still swimming and I had no energy. I do not feel the same as I did before the vaccine and I am so tired all the time.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Feeling hot, Fibrin D dimer increased, Headache, Mobility decreased
Clinical narrative: After I received the vaccine, I felt a warm sensation in my throat. Within 30 minutes of receiving the vaccine, I had a tightening in my chest, I started experiencing, chills and my body ached all over. Within 2 hours of receiving the vaccine, I was still experiencing the same symptoms but they were getting worse. Within 4 hours I felt I couldn't move and all I wanted to do was lay down.I slept for an hour. The symptoms were worse and I was short of breath and my head was swimming, I hurt all over, inside and out. I couldn't get up. I was like this for almost 16 hours. After 48 hours I was able to get to the bathroom and take a bath but symptoms were still there. After 6 more hours my fever broke. Its been 7 days and I am still experiencing a headache, body aches, chills, tightness of the chest, shortness of breath, my head is still swimming and I had no energy. I do not feel the same as I did before the vaccine and I am so tired all the time.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, Vertigo
Clinical narrative: After I received the vaccine, I felt a warm sensation in my throat. Within 30 minutes of receiving the vaccine, I had a tightening in my chest, I started experiencing, chills and my body ached all over. Within 2 hours of receiving the vaccine, I was still experiencing the same symptoms but they were getting worse. Within 4 hours I felt I couldn't move and all I wanted to do was lay down.I slept for an hour. The symptoms were worse and I was short of breath and my head was swimming, I hurt all over, inside and out. I couldn't get up. I was like this for almost 16 hours. After 48 hours I was able to get to the bathroom and take a bath but symptoms were still there. After 6 more hours my fever broke. Its been 7 days and I am still experiencing a headache, body aches, chills, tightness of the chest, shortness of breath, my head is still swimming and I had no energy. I do not feel the same as I did before the vaccine and I am so tired all the time.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case J&J 3/22/21 1802068 and boosted 11/13/21 FG3527 and 10/10/22 GJ2377
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: I developed an episodic headache began which is still on going. I also developed drainage in my throat a week later then tested positive for COVID-19 on 10/18/2022.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Dyspnoea, Gastric ulcer
Clinical narrative: COVID+ 12/2/2022.  Vaccination status - moderna x4 + Moderna BIVALENT BRIEF OVERVIEW:  Admission Date: 12/2/2022 Discharge Date: Dec 5, 2022 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up:   COVID pneumonia Bacterial pneumonia - Ceftin for 1 more day - isolate as able - Mask in public for next 5 days - Can discuss Paxlovid with PCP if desired - f/u blood cultures  Esophagitis Superficial gastric ulcers Hiatal hernia - PPI BID x8 weeks then daily - f/u PRN with GI - Limit NSAIDs - GERD lifestyle precautions - f/u biopsies - negative  HTN - Home meds resumed - Consider increasing doses if needed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Coffee ground emesis Community acquired pneumonia, unspecified laterality COVID-19 virus infection Pneumonia due to COVID-19 virus   HOSPITAL COURSE: The patient is a 78 y.o. male with PMHx of HTN, hearing loss with cochlear implant, CKD3, HLD, anxiety, prostate cancer, insomnia who presented to the ED with complaints of fever, cough and coffee ground emesis. He developed a fever and tested positive for COVID-19. He subsequently developed nausea with some coffee ground emesis along with productive cough and dyspnea. In the ER CXR with patchy airspace disease suggesting right basilar pneumonia. He was started on abx and admitted to medicine for pneumonia.   He was quickly weaned off supplemental oxygen. He continued on abx for bacterial pneumonia and was discharged with 1 more dose of Ceftin. When he presented he had significant coffee ground emesis and requested GI consult. Hemoglobin with drastic decrease from 14 to 10 and GI evaluated. EGD done on 12/4 with esophagitis, gastric ulcers, and hiatal hernia. Hemoglobin remained stable. Given his clinical stability he was discharged home on 12/5/22.  CONSULTS / RECOMMENDATION: GI - EGD done, see above for other findings/recs
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haematemesis, Haemoglobin decreased, Hiatus hernia, Hypoxia, Nausea
Clinical narrative: COVID+ 12/2/2022.  Vaccination status - moderna x4 + Moderna BIVALENT BRIEF OVERVIEW:  Admission Date: 12/2/2022 Discharge Date: Dec 5, 2022 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up:   COVID pneumonia Bacterial pneumonia - Ceftin for 1 more day - isolate as able - Mask in public for next 5 days - Can discuss Paxlovid with PCP if desired - f/u blood cultures  Esophagitis Superficial gastric ulcers Hiatal hernia - PPI BID x8 weeks then daily - f/u PRN with GI - Limit NSAIDs - GERD lifestyle precautions - f/u biopsies - negative  HTN - Home meds resumed - Consider increasing doses if needed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Coffee ground emesis Community acquired pneumonia, unspecified laterality COVID-19 virus infection Pneumonia due to COVID-19 virus   HOSPITAL COURSE: The patient is a 78 y.o. male with PMHx of HTN, hearing loss with cochlear implant, CKD3, HLD, anxiety, prostate cancer, insomnia who presented to the ED with complaints of fever, cough and coffee ground emesis. He developed a fever and tested positive for COVID-19. He subsequently developed nausea with some coffee ground emesis along with productive cough and dyspnea. In the ER CXR with patchy airspace disease suggesting right basilar pneumonia. He was started on abx and admitted to medicine for pneumonia.   He was quickly weaned off supplemental oxygen. He continued on abx for bacterial pneumonia and was discharged with 1 more dose of Ceftin. When he presented he had significant coffee ground emesis and requested GI consult. Hemoglobin with drastic decrease from 14 to 10 and GI evaluated. EGD done on 12/4 with esophagitis, gastric ulcers, and hiatal hernia. Hemoglobin remained stable. Given his clinical stability he was discharged home on 12/5/22.  CONSULTS / RECOMMENDATION: GI - EGD done, see above for other findings/recs
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oesophagitis, Oesophagogastroduodenoscopy abnormal, Pneumonia, Pneumonia bacterial, Productive cough
Clinical narrative: COVID+ 12/2/2022.  Vaccination status - moderna x4 + Moderna BIVALENT BRIEF OVERVIEW:  Admission Date: 12/2/2022 Discharge Date: Dec 5, 2022 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up:   COVID pneumonia Bacterial pneumonia - Ceftin for 1 more day - isolate as able - Mask in public for next 5 days - Can discuss Paxlovid with PCP if desired - f/u blood cultures  Esophagitis Superficial gastric ulcers Hiatal hernia - PPI BID x8 weeks then daily - f/u PRN with GI - Limit NSAIDs - GERD lifestyle precautions - f/u biopsies - negative  HTN - Home meds resumed - Consider increasing doses if needed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Coffee ground emesis Community acquired pneumonia, unspecified laterality COVID-19 virus infection Pneumonia due to COVID-19 virus   HOSPITAL COURSE: The patient is a 78 y.o. male with PMHx of HTN, hearing loss with cochlear implant, CKD3, HLD, anxiety, prostate cancer, insomnia who presented to the ED with complaints of fever, cough and coffee ground emesis. He developed a fever and tested positive for COVID-19. He subsequently developed nausea with some coffee ground emesis along with productive cough and dyspnea. In the ER CXR with patchy airspace disease suggesting right basilar pneumonia. He was started on abx and admitted to medicine for pneumonia.   He was quickly weaned off supplemental oxygen. He continued on abx for bacterial pneumonia and was discharged with 1 more dose of Ceftin. When he presented he had significant coffee ground emesis and requested GI consult. Hemoglobin with drastic decrease from 14 to 10 and GI evaluated. EGD done on 12/4 with esophagitis, gastric ulcers, and hiatal hernia. Hemoglobin remained stable. Given his clinical stability he was discharged home on 12/5/22.  CONSULTS / RECOMMENDATION: GI - EGD done, see above for other findings/recs
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: COVID+ 12/2/2022.  Vaccination status - moderna x4 + Moderna BIVALENT BRIEF OVERVIEW:  Admission Date: 12/2/2022 Discharge Date: Dec 5, 2022 Discharge Disposition:  home or self care   Active Issues Requiring Follow-up:   COVID pneumonia Bacterial pneumonia - Ceftin for 1 more day - isolate as able - Mask in public for next 5 days - Can discuss Paxlovid with PCP if desired - f/u blood cultures  Esophagitis Superficial gastric ulcers Hiatal hernia - PPI BID x8 weeks then daily - f/u PRN with GI - Limit NSAIDs - GERD lifestyle precautions - f/u biopsies - negative  HTN - Home meds resumed - Consider increasing doses if needed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Coffee ground emesis Community acquired pneumonia, unspecified laterality COVID-19 virus infection Pneumonia due to COVID-19 virus   HOSPITAL COURSE: The patient is a 78 y.o. male with PMHx of HTN, hearing loss with cochlear implant, CKD3, HLD, anxiety, prostate cancer, insomnia who presented to the ED with complaints of fever, cough and coffee ground emesis. He developed a fever and tested positive for COVID-19. He subsequently developed nausea with some coffee ground emesis along with productive cough and dyspnea. In the ER CXR with patchy airspace disease suggesting right basilar pneumonia. He was started on abx and admitted to medicine for pneumonia.   He was quickly weaned off supplemental oxygen. He continued on abx for bacterial pneumonia and was discharged with 1 more dose of Ceftin. When he presented he had significant coffee ground emesis and requested GI consult. Hemoglobin with drastic decrease from 14 to 10 and GI evaluated. EGD done on 12/4 with esophagitis, gastric ulcers, and hiatal hernia. Hemoglobin remained stable. Given his clinical stability he was discharged home on 12/5/22.  CONSULTS / RECOMMENDATION: GI - EGD done, see above for other findings/recs
Age: 15.0
Sex: F
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt was given flublok under age 18.  No known adverse effects
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Induration, Pain in extremity, Peripheral swelling
Clinical narrative: Arm very hard & sore  & solen
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient obtained 2 bivalent boosters in a 3-month span. 1st Pfizer bivalent booster 9/21/2022 and then 2nd Pfizer bivalent booster 12/7/2022.
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered below age requirement. No adverse reaction reported
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Aerococcus urinae infection, Anticoagulant therapy, Arrhythmia, Atrial fibrillation
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022 COVID positive Date 11/25/2022 Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022     HOSPITAL COURSE: Per HPI or hospital summary: "79 years old female with the past medical history of obesity, depression/anxiety, iron-def anemia, and UC with ileostomy, hx of DVT/PE, hx of obstructing ureteral stone, NICM, presented to ICU with septic shock from e. Coli bacteremia and e. Coli/aerococcus UTI will not have with right pyelonephritis without hydronephrosis or obstruction, as well as + COVID and entero/rhinovirus.  Course complicated by tachy-brady arrhythmias, multi-pressor shock, and AKI on CKD stage 3 requiring CRRT followed by dialysis.  Renal function continues to improve and was able to stop dialysis.  She was noted to have hold ATN diuresis with and was maintained on IV fluids a reverse oral hydration to help.  In   With patient's AFib and history of DVT she was managed on a heparin for reviewed tachy-brady syndrome with concern for needing cardioversion initially was transition to lower no with Eliquis with renal function along with amiodarone load.  And rice use a patient remained in sinus rhythm.       Follow ups  BMP 2-3 weeks may need increase in eliquis if renal function continues to improve close to higher dosing F/u WMC ziopatch at discharge     "   Interim hospital course:  Patient treated with antibiotics for pyelonephritis, receive Rocephin and plan to complete an additional 3-4 days of Omnicef at discharge to complete a course of therapy.  Patient to follow-up with Cardiology in the outpatient setting was started on amiodarone as well as low-dose Eliquis given renal function during her hospital stay.  ZIO patch placed prior to discharge will need outpatient follow-up with Cardiology to continue her care as well as dose adjust Eliquis of her renal function continues to improve.  Recommend follow-up with primary care physician the next 1-2 weeks.  Patient seen by PT OT with plans discharge to subacute rehab today with transportation set up at 17:00 per care management.  Medically stable for discharge to subacute rehab on 12/06/2022.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac monitoring, Chronic kidney disease, Dialysis, Enterovirus infection
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022 COVID positive Date 11/25/2022 Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022     HOSPITAL COURSE: Per HPI or hospital summary: "79 years old female with the past medical history of obesity, depression/anxiety, iron-def anemia, and UC with ileostomy, hx of DVT/PE, hx of obstructing ureteral stone, NICM, presented to ICU with septic shock from e. Coli bacteremia and e. Coli/aerococcus UTI will not have with right pyelonephritis without hydronephrosis or obstruction, as well as + COVID and entero/rhinovirus.  Course complicated by tachy-brady arrhythmias, multi-pressor shock, and AKI on CKD stage 3 requiring CRRT followed by dialysis.  Renal function continues to improve and was able to stop dialysis.  She was noted to have hold ATN diuresis with and was maintained on IV fluids a reverse oral hydration to help.  In   With patient's AFib and history of DVT she was managed on a heparin for reviewed tachy-brady syndrome with concern for needing cardioversion initially was transition to lower no with Eliquis with renal function along with amiodarone load.  And rice use a patient remained in sinus rhythm.       Follow ups  BMP 2-3 weeks may need increase in eliquis if renal function continues to improve close to higher dosing F/u WMC ziopatch at discharge     "   Interim hospital course:  Patient treated with antibiotics for pyelonephritis, receive Rocephin and plan to complete an additional 3-4 days of Omnicef at discharge to complete a course of therapy.  Patient to follow-up with Cardiology in the outpatient setting was started on amiodarone as well as low-dose Eliquis given renal function during her hospital stay.  ZIO patch placed prior to discharge will need outpatient follow-up with Cardiology to continue her care as well as dose adjust Eliquis of her renal function continues to improve.  Recommend follow-up with primary care physician the next 1-2 weeks.  Patient seen by PT OT with plans discharge to subacute rehab today with transportation set up at 17:00 per care management.  Medically stable for discharge to subacute rehab on 12/06/2022.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Escherichia bacteraemia, Haemofiltration, Intensive care, Pyelonephritis, Renal impairment
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022 COVID positive Date 11/25/2022 Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022     HOSPITAL COURSE: Per HPI or hospital summary: "79 years old female with the past medical history of obesity, depression/anxiety, iron-def anemia, and UC with ileostomy, hx of DVT/PE, hx of obstructing ureteral stone, NICM, presented to ICU with septic shock from e. Coli bacteremia and e. Coli/aerococcus UTI will not have with right pyelonephritis without hydronephrosis or obstruction, as well as + COVID and entero/rhinovirus.  Course complicated by tachy-brady arrhythmias, multi-pressor shock, and AKI on CKD stage 3 requiring CRRT followed by dialysis.  Renal function continues to improve and was able to stop dialysis.  She was noted to have hold ATN diuresis with and was maintained on IV fluids a reverse oral hydration to help.  In   With patient's AFib and history of DVT she was managed on a heparin for reviewed tachy-brady syndrome with concern for needing cardioversion initially was transition to lower no with Eliquis with renal function along with amiodarone load.  And rice use a patient remained in sinus rhythm.       Follow ups  BMP 2-3 weeks may need increase in eliquis if renal function continues to improve close to higher dosing F/u WMC ziopatch at discharge     "   Interim hospital course:  Patient treated with antibiotics for pyelonephritis, receive Rocephin and plan to complete an additional 3-4 days of Omnicef at discharge to complete a course of therapy.  Patient to follow-up with Cardiology in the outpatient setting was started on amiodarone as well as low-dose Eliquis given renal function during her hospital stay.  ZIO patch placed prior to discharge will need outpatient follow-up with Cardiology to continue her care as well as dose adjust Eliquis of her renal function continues to improve.  Recommend follow-up with primary care physician the next 1-2 weeks.  Patient seen by PT OT with plans discharge to subacute rehab today with transportation set up at 17:00 per care management.  Medically stable for discharge to subacute rehab on 12/06/2022.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinovirus infection, SARS-CoV-2 test positive, Septic shock, Shock, Sinus node dysfunction
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022 COVID positive Date 11/25/2022 Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022     HOSPITAL COURSE: Per HPI or hospital summary: "79 years old female with the past medical history of obesity, depression/anxiety, iron-def anemia, and UC with ileostomy, hx of DVT/PE, hx of obstructing ureteral stone, NICM, presented to ICU with septic shock from e. Coli bacteremia and e. Coli/aerococcus UTI will not have with right pyelonephritis without hydronephrosis or obstruction, as well as + COVID and entero/rhinovirus.  Course complicated by tachy-brady arrhythmias, multi-pressor shock, and AKI on CKD stage 3 requiring CRRT followed by dialysis.  Renal function continues to improve and was able to stop dialysis.  She was noted to have hold ATN diuresis with and was maintained on IV fluids a reverse oral hydration to help.  In   With patient's AFib and history of DVT she was managed on a heparin for reviewed tachy-brady syndrome with concern for needing cardioversion initially was transition to lower no with Eliquis with renal function along with amiodarone load.  And rice use a patient remained in sinus rhythm.       Follow ups  BMP 2-3 weeks may need increase in eliquis if renal function continues to improve close to higher dosing F/u WMC ziopatch at discharge     "   Interim hospital course:  Patient treated with antibiotics for pyelonephritis, receive Rocephin and plan to complete an additional 3-4 days of Omnicef at discharge to complete a course of therapy.  Patient to follow-up with Cardiology in the outpatient setting was started on amiodarone as well as low-dose Eliquis given renal function during her hospital stay.  ZIO patch placed prior to discharge will need outpatient follow-up with Cardiology to continue her care as well as dose adjust Eliquis of her renal function continues to improve.  Recommend follow-up with primary care physician the next 1-2 weeks.  Patient seen by PT OT with plans discharge to subacute rehab today with transportation set up at 17:00 per care management.  Medically stable for discharge to subacute rehab on 12/06/2022.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022 COVID positive Date 11/25/2022 Discharge Provider: MD Primary Care Provider at Discharge: PA-C  Admission Date: 11/25/2022 Discharge Date: 12/06/2022     HOSPITAL COURSE: Per HPI or hospital summary: "79 years old female with the past medical history of obesity, depression/anxiety, iron-def anemia, and UC with ileostomy, hx of DVT/PE, hx of obstructing ureteral stone, NICM, presented to ICU with septic shock from e. Coli bacteremia and e. Coli/aerococcus UTI will not have with right pyelonephritis without hydronephrosis or obstruction, as well as + COVID and entero/rhinovirus.  Course complicated by tachy-brady arrhythmias, multi-pressor shock, and AKI on CKD stage 3 requiring CRRT followed by dialysis.  Renal function continues to improve and was able to stop dialysis.  She was noted to have hold ATN diuresis with and was maintained on IV fluids a reverse oral hydration to help.  In   With patient's AFib and history of DVT she was managed on a heparin for reviewed tachy-brady syndrome with concern for needing cardioversion initially was transition to lower no with Eliquis with renal function along with amiodarone load.  And rice use a patient remained in sinus rhythm.       Follow ups  BMP 2-3 weeks may need increase in eliquis if renal function continues to improve close to higher dosing F/u WMC ziopatch at discharge     "   Interim hospital course:  Patient treated with antibiotics for pyelonephritis, receive Rocephin and plan to complete an additional 3-4 days of Omnicef at discharge to complete a course of therapy.  Patient to follow-up with Cardiology in the outpatient setting was started on amiodarone as well as low-dose Eliquis given renal function during her hospital stay.  ZIO patch placed prior to discharge will need outpatient follow-up with Cardiology to continue her care as well as dose adjust Eliquis of her renal function continues to improve.  Recommend follow-up with primary care physician the next 1-2 weeks.  Patient seen by PT OT with plans discharge to subacute rehab today with transportation set up at 17:00 per care management.  Medically stable for discharge to subacute rehab on 12/06/2022.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Brain natriuretic peptide increased, COVID-19, Cardiac failure congestive, Catheterisation cardiac abnormal
Clinical narrative: Patient is nontoxic-appearing 70-year-old female with a history of coronary artery disease and CHF with a LifeVest on and recent heart catheterization at the end of November with patent vessels and a EF of 20 to 25% presents the emergency department ambulatory for shortness of breath.  Patient states that is gotten worse over the last 24 hours.  She denies any productive cough.  She has no leg swelling however states that she normally does not get leg swelling whenever she puts on water weight.  Yesterday she weighed 170 pounds this morning she was 178.  Denies any chest pain.  No fevers. Associated Symptoms: orthopnea, paraoxysmal nocturnal dyspnea, shortness of breath
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Dyspnoea exertional, Dyspnoea paroxysmal nocturnal, Ejection fraction decreased
Clinical narrative: Patient is nontoxic-appearing 70-year-old female with a history of coronary artery disease and CHF with a LifeVest on and recent heart catheterization at the end of November with patent vessels and a EF of 20 to 25% presents the emergency department ambulatory for shortness of breath.  Patient states that is gotten worse over the last 24 hours.  She denies any productive cough.  She has no leg swelling however states that she normally does not get leg swelling whenever she puts on water weight.  Yesterday she weighed 170 pounds this morning she was 178.  Denies any chest pain.  No fevers. Associated Symptoms: orthopnea, paraoxysmal nocturnal dyspnea, shortness of breath
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Laboratory test, Orthopnoea, Patent ductus arteriosus, SARS-CoV-2 test positive
Clinical narrative: Patient is nontoxic-appearing 70-year-old female with a history of coronary artery disease and CHF with a LifeVest on and recent heart catheterization at the end of November with patent vessels and a EF of 20 to 25% presents the emergency department ambulatory for shortness of breath.  Patient states that is gotten worse over the last 24 hours.  She denies any productive cough.  She has no leg swelling however states that she normally does not get leg swelling whenever she puts on water weight.  Yesterday she weighed 170 pounds this morning she was 178.  Denies any chest pain.  No fevers. Associated Symptoms: orthopnea, paraoxysmal nocturnal dyspnea, shortness of breath
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin, Weight increased
Clinical narrative: Patient is nontoxic-appearing 70-year-old female with a history of coronary artery disease and CHF with a LifeVest on and recent heart catheterization at the end of November with patent vessels and a EF of 20 to 25% presents the emergency department ambulatory for shortness of breath.  Patient states that is gotten worse over the last 24 hours.  She denies any productive cough.  She has no leg swelling however states that she normally does not get leg swelling whenever she puts on water weight.  Yesterday she weighed 170 pounds this morning she was 178.  Denies any chest pain.  No fevers. Associated Symptoms: orthopnea, paraoxysmal nocturnal dyspnea, shortness of breath
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: 11 yo came in for 2nd Pfizer dose of her primary series. She was given the Pfizer bivalent dose.  No symptoms or any reactions.  Just needed to report. Vials look identical and was mistaken for primary series.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Bladder cancer, Bladder disorder, COVID-19, Cough, Headache
Clinical narrative: I had a sore throat, severe headache, sneezing, slight cough. I took an at-home COVID-19 which came back positive, so I went to a clinic to take a PCR test to confirm which came back positive. My doctor recommended that I got the monoclonal antibody infusion and sent someone to my home to administer it. Within 36 hours later, I was symptom-free and doing much better. He also prescribed me PAXLOVID but suggested I didn't take it and do the infusion instead. As of now I'm fine, but have been having some bladder issues since then. I visited my urologist who said I was diagnosed with bladder cancer.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Oropharyngeal pain, SARS-CoV-2 test positive, Sneezing, Urine analysis
Clinical narrative: I had a sore throat, severe headache, sneezing, slight cough. I took an at-home COVID-19 which came back positive, so I went to a clinic to take a PCR test to confirm which came back positive. My doctor recommended that I got the monoclonal antibody infusion and sent someone to my home to administer it. Within 36 hours later, I was symptom-free and doing much better. He also prescribed me PAXLOVID but suggested I didn't take it and do the infusion instead. As of now I'm fine, but have been having some bladder issues since then. I visited my urologist who said I was diagnosed with bladder cancer.
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 28.0
Sex: F
Vaccine: VARCEL
Symptoms: Extra dose administered
Clinical narrative: Medical assistant working schedule gave varicella vaccine to the patient and she had already received the vaccine less than two weeks ago. MA working schedule came to writer with questions related to entering an immunization given to the patient. When assisting MA with entering immunization order it was discovered the patient had already been given the immunization based on lab results and provider message stating she [patient] needed the medication. 1st Varicella noted to be administered on 11/14/2022. Second dose of Varicella given on 11/30/2022. Both vaccines were documented to be given by provider. 1st time after results for Varicella Zoster IGM resulted on 11/07/22. 2nd time after Varicella Zoster IGG resulted on was resulted 11/18/22.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, Blood bicarbonate normal, Blood chloride increased, Blood creatinine normal
Clinical narrative: COVID+ 12/4/2022.  Vaccination Status - Moderna x3 Attending Physician: MD Date of Admission: 12/4/2022, Hospital Day: 3 Date of Discharge: 12/6/2022   BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD       Active Hospital Problems   Diagnosis Date Noted POA ? Syncope 12/04/2022 Yes ? COVID-19 virus infection 12/04/2022 Yes ? COVID-19 12/04/2022 Yes ? Moderate persistent asthma without complication 09/02/2022 Yes ? FH: CAD (coronary artery disease) 03/24/2014 Yes ? Former smoker 11/16/2011 Yes ? Obesity   Yes ? Hyperlipemia 01/07/2009 Yes ? Hypertension   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Syncope, unspecified syncope type [R55] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 year old female who presented after a syncopal episode at home. Her husband heard her fall and noted confusion afterwards and called EMS. Workup in the ER was negative, though patient was markedly weak (unable to stand on her own) and therefore admitted to medicine for further management. She was found to be COVID positive as well. Upon admission she was started on IV fluids. She remained on room air. TTE was done for syncope and showed EF 63%, severe mitral annular calcification, no RWMA. PT was consulted and recommended returning home with assistance.  ZIO patch was placed at discharge.  The patient was discharged home in stable and improved condition.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood urea normal, COVID-19
Clinical narrative: COVID+ 12/4/2022.  Vaccination Status - Moderna x3 Attending Physician: MD Date of Admission: 12/4/2022, Hospital Day: 3 Date of Discharge: 12/6/2022   BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD       Active Hospital Problems   Diagnosis Date Noted POA ? Syncope 12/04/2022 Yes ? COVID-19 virus infection 12/04/2022 Yes ? COVID-19 12/04/2022 Yes ? Moderate persistent asthma without complication 09/02/2022 Yes ? FH: CAD (coronary artery disease) 03/24/2014 Yes ? Former smoker 11/16/2011 Yes ? Obesity   Yes ? Hyperlipemia 01/07/2009 Yes ? Hypertension   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Syncope, unspecified syncope type [R55] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 year old female who presented after a syncopal episode at home. Her husband heard her fall and noted confusion afterwards and called EMS. Workup in the ER was negative, though patient was markedly weak (unable to stand on her own) and therefore admitted to medicine for further management. She was found to be COVID positive as well. Upon admission she was started on IV fluids. She remained on room air. TTE was done for syncope and showed EF 63%, severe mitral annular calcification, no RWMA. PT was consulted and recommended returning home with assistance.  ZIO patch was placed at discharge.  The patient was discharged home in stable and improved condition.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Confusional state, Dysstasia, Echocardiogram, Ejection fraction normal
Clinical narrative: COVID+ 12/4/2022.  Vaccination Status - Moderna x3 Attending Physician: MD Date of Admission: 12/4/2022, Hospital Day: 3 Date of Discharge: 12/6/2022   BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: MD       Active Hospital Problems   Diagnosis Date Noted POA ? Syncope 12/04/2022 Yes ? COVID-19 virus infection 12/04/2022 Yes ? COVID-19 12/04/2022 Yes ? Moderate persistent asthma without complication 09/02/2022 Yes ? FH: CAD (coronary artery disease) 03/24/2014 Yes ? Former smoker 11/16/2011 Yes ? Obesity   Yes ? Hyperlipemia 01/07/2009 Yes ? Hypertension   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Syncope, unspecified syncope type [R55] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 year old female who presented after a syncopal episode at home. Her husband heard her fall and noted confusion afterwards and called EMS. Workup in the ER was negative, though patient was markedly weak (unable to stand on her own) and therefore admitted to medicine for further management. She was found to be COVID positive as well. Upon admission she was started on IV fluids. She remained on room air. TTE was done for syncope and showed EF 63%, severe mitral annular calcification, no RWMA. PT was consulted and recommended returning home with assistance.  ZIO patch was placed at discharge.  The patient was discharged home in stable and improved condition.